Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Cause Platelet count decreased? 130 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Platelet count decreased have been filed in association with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (PLUVICTO). This represents 1.2% of all adverse event reports for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN.
130
Reports of Platelet count decreased with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
1.2%
of all LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN reports
18
Deaths
14
Hospitalizations
How Dangerous Is Platelet count decreased From LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN?
Of the 130 reports, 18 (13.8%) resulted in death, 14 (10.8%) required hospitalization, and 2 (1.5%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Cause?
General physical health deterioration (4,332)
Ill-defined disorder (3,600)
Death (1,179)
Disease progression (286)
Malignant neoplasm progression (251)
Laboratory test abnormal (233)
Prostatic specific antigen increased (212)
Fatigue (177)
Anaemia (154)
Covid-19 (139)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Alternatives Have Lower Platelet count decreased Risk?
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTETIUM OXODOTREOTIDE LU-177
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTROPIN ALFA
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYMECYCLINE
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYRICA
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYSERGIDE